Mutation Profiling of Premalignant Colorectal Neoplasia

Overview

Journal Gastroenterol Res Pract

Publisher Wiley

Specialty Gastroenterology

Date 2019 Nov 30

PMID 31781186

Citations 7

Authors

Jakub Karczmarski

Krzysztof Goryca

Jacek Pachlewski

Michalina Dabrowska

Kazimiera Pysniak

Agnieszka Paziewska

Maria Kulecka

Malgorzata Lenarcik

Andrzej Mroz

Michal Mikula

Jerzy Ostrowski

Affiliations

Soon will be listed here.

Abstract

Accumulation of allelic variants in genes that regulate cellular proliferation, differentiation, and apoptosis may result in expansion of the aberrant intestinal epithelium, generating adenomas. Herein, we compared the mutation profiles of conventional colorectal adenomas (CNADs) across stages of progression towards early carcinoma. DNA was isolated from 17 invasive adenocarcinomas (ACs) and 58 large CNADs, including 19 with low-grade dysplasia (LGD), 21 with LGD adjacent to areas of high-grade dysplasia and/or carcinoma (LGD-H), and 28 with high-grade dysplasia (HGD). Ion AmpliSeq Comprehensive Cancer Panel libraries were prepared and sequenced on the Ion Proton. We identified 956 unique allelic variants; of these, 499 were considered nonsynonymous variants. Eleven genes (, , , , , , , , , , and ) were mutated in at least 15% of all samples. Out of frequently mutated genes, and had a consistent trend in mutation prevalence towards malignancy, while two other genes ( and ) exhibited the opposite trend. HGD adenomas had significantly higher mutation rates than LGD adenomas, while LGD-H adenomas exhibited mutation frequencies similar to those of LGD adenomas. A significant increase in copy number variant frequency was observed from LGD through HGD to malignant samples. The profiling of advanced CNADs demonstrated variations in mutation patterns among colorectal premalignancies. Only limited numbers of genes were repeatedly mutated while the majority were altered in single cases. Most genetic alterations in adenomas can be considered early contributors to colorectal carcinogenesis.

Citing Articles

Molecular characterization of colorectal cancer (CRC) using next generation sequencing (NGS) in bridging the gap between research and clinical practice: from biomarker discovery to clinical implementation.

Afolabi H, Salleh S, Zakaria Z, Seng C, Nafi S, Aziz A Discov Oncol. 2025; 16(1):268.

PMID: 40048017 PMC: 11885200. DOI: 10.1007/s12672-025-01960-2.

In Vitro Cytotoxicity of Fluorinated Quaternary Ammonium Salts in Colorectal Cancer Cells and In Silico Pharmacology.

Aponte A, Ospina V, Pulido S, Rios-Vasquez L, Jaramillo L, Muneton Pena C Adv Pharmacol Pharm Sci. 2024; 2024:2671547.

PMID: 39512304 PMC: 11540889. DOI: 10.1155/2024/2671547.

Targeted variant prevalence of FBXW7 gene mutation in colorectal carcinoma propagation. The first systematic review and meta-analysis.

Afolabi H, Salleh S, Zakaria Z, Seng C, Nafi N, Bin AbdulAziz A Heliyon. 2024; 10(11):e31471.

PMID: 38845996 PMC: 11154211. DOI: 10.1016/j.heliyon.2024.e31471.

Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature.

Guo X, Lei R, Zhou Q, Zhang G, Hu B, Liang Y BMC Cancer. 2023; 23(1):773.

PMID: 37596528 PMC: 10436413. DOI: 10.1186/s12885-023-11277-4.

Biallelic FBXW7 knockout induces AKAP8-mediated DNA damage in neighbouring wildtype cells.

Chan D, Mandal A, Hester S, Yu Z, Higgins G, Kessler B Cell Death Discov. 2023; 9(1):200.

PMID: 37386001 PMC: 10310709. DOI: 10.1038/s41420-023-01494-y.

References

IJspeert J, Medema J, Dekker E . Colorectal neoplasia pathways: state of the art. Gastrointest Endosc Clin N Am. 2015; 25(2):169-82. DOI: 10.1016/j.giec.2014.11.004. View

Sottoriva A, Kang H, Ma Z, Graham T, Salomon M, Zhao J . A Big Bang model of human colorectal tumor growth. Nat Genet. 2015; 47(3):209-16. PMC: 4575589. DOI: 10.1038/ng.3214. View

Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U . Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut. 2007; 56(11):1585-9. PMC: 2095643. DOI: 10.1136/gut.2007.122739. View

Rowan A, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A . APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci U S A. 2000; 97(7):3352-7. PMC: 16243. DOI: 10.1073/pnas.97.7.3352. View

Ng P, Henikoff S . SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31(13):3812-4. PMC: 168916. DOI: 10.1093/nar/gkg509. View

Bailey M, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A . Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell. 2018; 173(2):371-385.e18. PMC: 6029450. DOI: 10.1016/j.cell.2018.02.060. View

Sudmant P, Rausch T, Gardner E, Handsaker R, Abyzov A, Huddleston J . An integrated map of structural variation in 2,504 human genomes. Nature. 2015; 526(7571):75-81. PMC: 4617611. DOI: 10.1038/nature15394. View

Punt C, Koopman M, Vermeulen L . From tumour heterogeneity to advances in precision treatment of colorectal cancer. Nat Rev Clin Oncol. 2016; 14(4):235-246. DOI: 10.1038/nrclinonc.2016.171. View

Douville C, Carter H, Kim R, Niknafs N, Diekhans M, Stenson P . CRAVAT: cancer-related analysis of variants toolkit. Bioinformatics. 2013; 29(5):647-8. PMC: 3582272. DOI: 10.1093/bioinformatics/btt017. View

10.

Rubio C, Nesi G, Messerini L, Zampi G, Mandai K, Itabashi M . The Vienna classification applied to colorectal adenomas. J Gastroenterol Hepatol. 2006; 21(11):1697-703. DOI: 10.1111/j.1440-1746.2006.04258.x. View

11.

Vogelstein B, Papadopoulos N, Velculescu V, Zhou S, Diaz Jr L, Kinzler K . Cancer genome landscapes. Science. 2013; 339(6127):1546-58. PMC: 3749880. DOI: 10.1126/science.1235122. View

12.

Fimereli D, Fumagalli D, Brown D, Gacquer D, Rothe F, Salgado R . Genomic hotspots but few recurrent fusion genes in breast cancer. Genes Chromosomes Cancer. 2018; 57(7):331-338. DOI: 10.1002/gcc.22533. View

13.

Zauber P, Marotta S, Sabbath-Solitare M . GNAS gene mutation may be present only transiently during colorectal tumorigenesis. Int J Mol Epidemiol Genet. 2016; 7(1):24-31. PMC: 4858613. View

14.

Scherer S, Lee C, Birney E, Altshuler D, Eichler E, Carter N . Challenges and standards in integrating surveys of structural variation. Nat Genet. 2007; 39(7 Suppl):S7-15. PMC: 2698291. DOI: 10.1038/ng2093. View

15.

Druliner B, Ruan X, Sicotte H, OBrien D, Liu H, Kocher J . Early genetic aberrations in patients with sporadic colorectal cancer. Mol Carcinog. 2017; 57(1):114-124. PMC: 5716916. DOI: 10.1002/mc.22738. View

16.

Burmer G, Loeb L . Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci U S A. 1989; 86(7):2403-7. PMC: 286921. DOI: 10.1073/pnas.86.7.2403. View

17.

Tomasetti C, Marchionni L, Nowak M, Parmigiani G, Vogelstein B . Only three driver gene mutations are required for the development of lung and colorectal cancers. Proc Natl Acad Sci U S A. 2014; 112(1):118-23. PMC: 4291633. DOI: 10.1073/pnas.1421839112. View

18.

Carter H, Chen S, Isik L, Tyekucheva S, Velculescu V, Kinzler K . Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res. 2009; 69(16):6660-7. PMC: 2763410. DOI: 10.1158/0008-5472.CAN-09-1133. View

19.

Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T . Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016; 536(7616):285-91. PMC: 5018207. DOI: 10.1038/nature19057. View

20.

Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164. PMC: 2938201. DOI: 10.1093/nar/gkq603. View